These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16129824)

  • 21. Transferrin receptor 1.
    Aisen P
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2137-43. PubMed ID: 15313461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the hemochromatosis (HFE) gene modulates the cellular uptake of 67Ga.
    Chitambar CR; Wereley JP
    J Nucl Med; 2003 Jun; 44(6):943-6. PubMed ID: 12791823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor.
    Bennett MJ; Lebrón JA; Bjorkman PJ
    Nature; 2000 Jan; 403(6765):46-53. PubMed ID: 10638746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron, HFE, and hemochromatosis update.
    Cuthbert JA
    J Investig Med; 1997 Dec; 45(9):518-29. PubMed ID: 9444878
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemochromatosis: a genetic defect in iron metabolism.
    Jazwinska EC
    Bioessays; 1998 Jul; 20(7):562-8. PubMed ID: 9723005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current approach to hemochromatosis.
    Brissot P; Troadec MB; Bardou-Jacquet E; Le Lan C; Jouanolle AM; Deugnier Y; Loréal O
    Blood Rev; 2008 Jul; 22(4):195-210. PubMed ID: 18430498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
    Distante S
    Scand J Clin Lab Invest; 2006; 66(2):83-100. PubMed ID: 16537242
    [No Abstract]   [Full Text] [Related]  

  • 28. Hfe acts in hepatocytes to prevent hemochromatosis.
    Vujić Spasić M; Kiss J; Herrmann T; Galy B; Martinache S; Stolte J; Gröne HJ; Stremmel W; Hentze MW; Muckenthaler MU
    Cell Metab; 2008 Feb; 7(2):173-8. PubMed ID: 18249176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?
    Ioannou GN; Kowdley KV
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):246-8. PubMed ID: 15017663
    [No Abstract]   [Full Text] [Related]  

  • 30. Unusual MHC-like molecules: CD1, Fc receptor, the hemochromatosis gene product, and viral homologs.
    Wilson IA; Bjorkman PJ
    Curr Opin Immunol; 1998 Feb; 10(1):67-73. PubMed ID: 9523114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha.
    Constante M; Wang D; Raymond VA; Bilodeau M; Santos MM
    Am J Pathol; 2007 Feb; 170(2):497-504. PubMed ID: 17255318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective role of calreticulin in HFE hemochromatosis.
    Pinto JP; Ramos P; de Almeida SF; Oliveira S; Breda L; Michalak M; Porto G; Rivella S; de Sousa M
    Free Radic Biol Med; 2008 Jan; 44(1):99-108. PubMed ID: 18045552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation.
    Constante M; Jiang W; Wang D; Raymond VA; Bilodeau M; Santos MM
    Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G229-37. PubMed ID: 16565419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HFE, iron homeostasis and genetic hemochromatosis.
    Cazzola M
    Haematologica; 2000 Apr; 85(4):338-9. PubMed ID: 10756355
    [No Abstract]   [Full Text] [Related]  

  • 35. The T-cell repertoire for antigen and MHC.
    Marrack P; Kappler J
    Immunol Today; 1988 Oct; 9(10):308-15. PubMed ID: 3076400
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells.
    Agrawal S; Marquet J; Freeman GJ; Tawab A; Bouteiller PL; Roth P; Bolton W; Ogg G; Boumsell L; Bensussan A
    J Immunol; 1999 Feb; 162(3):1223-6. PubMed ID: 9973372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen presentation: structural themes and functional variations.
    Braciale TJ; Braciale VL
    Immunol Today; 1991 Apr; 12(4):124-9. PubMed ID: 1711855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel (Leu183Pro-)mutation in the HFE-gene co-inherited with the Cys282Tyr mutation in two unrelated Dutch hemochromatosis patients.
    Swinkels DW; Venselaar H; Wiegerinck ET; Bakker E; Joosten I; Jaspers CA; Vasmel WL; Breuning MH
    Blood Cells Mol Dis; 2008; 40(3):334-8. PubMed ID: 18042412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE.
    Lee SY; Patton SM; Henderson RJ; Connor JR
    FASEB J; 2007 Feb; 21(2):564-76. PubMed ID: 17194693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class (I) will come to order--not.
    Strong RK
    Nat Struct Biol; 2000 Mar; 7(3):173-6. PubMed ID: 10700267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.